At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 34 enrolled
Drug / intervention
Diacerein 1% ointmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 4 Day, Randomized Study to Evaluate the Potential of CCP-020 (Diacerein 1%) Topical Ointment to Induce a Phototoxicity Skin Reaction in Healthy Subjects, Using a Controlled Photopatch Test
In Brief
A Phase 1 clinical trial evaluating Diacerein 1% ointment for Healthy. Completed, enrolled 34 participants across 1 site.
Detailed Summary
This study was designed to assess the phototoxic potential of diacerein 1% ointment when application is followed by light exposure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
Primary CompletionDec 2017
First PostedMar 2018
TodayJul 2026
First PostedMar 22, 2018
Enrollment StartDec 12, 2017
Primary CompletionDec 15, 2017
TodayJul 2, 2026
Enrollment to primary: 3 daysPosted 8.3 years ago
Interventions
Diacerein 1% ointmentdrug
Diacerein 1% ointment and vehicle ointment were applied on Day 1 at two randomly assigned skin sites on each side of the lower thoracic area of the back according to a randomization scheme. One side of the back was irradiated on Day 2, including an untreated irradiated control site, and the other side was to remain non-irradiated.